MSc Belen Fraile

Belen Fraile, MD, MSc, MBA, is a prominent healthcare executive currently serving as the Chief Data & Digital Officer (CDO) and Head of Innovation for the US Oncology division at Novartis. With over 15 years of experience in various sectors of healthcare, including clinical practice, hospital administration, healthcare policy, academia, and pharmaceuticals, Dr. Fraile has established herself as a leader in data and digital transformation within the oncology field.

Educational Background

Dr. Fraile holds an MD from Complutense University of Madrid, Spain, an MSc in Health Care Policy and Management from the Harvard School of Public Health, and an MBA from MIT Sloan School of Management. She was awarded a Fulbright Scholarship in 2010 and has received several institutional awards throughout her career.

Professional Experience

Before joining Novartis, Dr. Fraile led the Population Health Management and Enterprise Analytics team at Dana-Farber Cancer Institute, which is affiliated with Harvard Medical School. In her current role at Novartis, she is responsible for:

• Leading strategic initiatives to enhance clinical innovation and patient journeys through data and digital solutions.
• Overseeing a team of over 100 professionals focused on data strategy, digital marketing, enterprise analytics, and operational execution across commercial and medical sectors.
• Engaging with healthcare providers, payers, and other stakeholders to improve cancer care delivery.

Dr. Fraile's work includes developing analytic models to interpret complex healthcare data and implementing innovative payment methodologies aimed at improving patient outcomes.1